Skip to main content

Advertisement

Table 3 Molecular markers of P. falciparum anti-malarial resistance

From: Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia

Genes SNP Wild-type Mutant
Pfmdr1 Multi-drug resistance N86Y 8 (47.0%) 9 (52.9%)
L155L (Syn) 16 (94.1%) 1 (5.9%)
Y184F 7 (41.2%) 10 (58.8%)
S1034C 17 (100.0%) 0 (0%)
N1042D 17 (100.0%) 0 (0%)
D1246Y 15 (88.2%) 2 (11.8%)
Pfdhps Sulfadoxine S436A 12 (70.6%) 5 (29.4%)
A437G 14 (82.3%) 3 (17.6%)
K540E 17 (100.0%) 0 (0%)
A581G 16 (94.1%) 1 (5.9%)
A613S 15 (88.2%) 2 (11.8%)
Pfcrt Chloroquine M74I 2 (11.8%) 15 (88.2%)
N75E 2 (11.8%) 15 (88.2%)
K76T 2 (11.8%) 15 (88.2%)
I77I (Syn) 16 (94.1%) 1 (5.9%)
I103I (Syn) 16 (94.1%) 1 (5.9%)
K13 Artemisinin V510V (Syn) 16 (94.1%) 1 (5.9%)
  1. SNP single nucleotide polymorphisms, Syn synonymous mutation (no amino acid change)